Persistence Market Research Company
Customize Now Get FREE Sample

Proton Pump Inhibitors (PPI) Market Size, Share, and Growth Forecast, 2026 - 2033

Proton Pump Inhibitors (PPI) Market by Drug Class (Omeprazole, Esomeprazole, Pantoprazole, Lansoprazole, P-CABs, Others), Therapeutic Indication (GERD, PUD, H. pylori Infection, Stress Ulcer Prophylaxis, Zollinger-Ellison Syndrome, NSAID-Induced Gastropathy Prophylaxis), Route of Administration (Oral, Intravenous), and Regional Analysis for 2026 - 2033

ID: PMRREP36048| 210 Pages | 24 Jan 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Proton Pump Inhibitors (PPI) Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Product Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2025A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Drug Class
  5. Global Proton Pump Inhibitors (PPI) Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2026 - 2033
    3. Global Proton Pump Inhibitors (PPI) Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Drug Class, 2020 - 2025
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 - 2033
        1. Omeprazole
        2. Esomeprazole
        3. Pantoprazole
        4. Lansoprazole
        5. Potassium-Competitive Acid Blockers (P-CABs)
        6. Others
      4. Market Attractiveness Analysis: Drug Class
    4. Global Proton Pump Inhibitors (PPI) Market Outlook: Therapeutic Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Indication, 2020 - 2025
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Indication, 2026 - 2033
        1. Gastroesophageal Reflux Disease (GERD)
        2. Peptic Ulcer Disease (PUD)
        3. H. pylori Infection
        4. Stress Ulcer Prophylaxis
        5. Zollinger-Ellison Syndrome
        6. Nonsteroidal Anti-Inflammatory Drug (NSAID)-Induced Gastropathy Prophylaxis
      4. Market Attractiveness Analysis: Therapeutic Indication
    5. Global Proton Pump Inhibitors (PPI) Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2020 - 2025
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2026 - 2033
        1. Oral
        2. Intravenous
      4. Market Attractiveness Analysis: Route of Administration
  6. Global Proton Pump Inhibitors (PPI) Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2020 - 2025
    3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2026 - 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Proton Pump Inhibitors (PPI) Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Drug Class
      3. By Therapeutic Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 - 2033
      1. Omeprazole
      2. Esomeprazole
      3. Pantoprazole
      4. Lansoprazole
      5. Potassium-Competitive Acid Blockers (P-CABs)
      6. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Indication, 2026 - 2033
      1. Gastroesophageal Reflux Disease (GERD)
      2. Peptic Ulcer Disease (PUD)
      3. H. pylori Infection
      4. Stress Ulcer Prophylaxis
      5. Zollinger-Ellison Syndrome
      6. Nonsteroidal Anti-Inflammatory Drug (NSAID)-Induced Gastropathy Prophylaxis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Intravenous
    7. Market Attractiveness Analysis
  8. Europe Proton Pump Inhibitors (PPI) Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Drug Class
      3. By Therapeutic Indication
      4. Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 - 2033
      1. Omeprazole
      2. Esomeprazole
      3. Pantoprazole
      4. Lansoprazole
      5. Potassium-Competitive Acid Blockers (P-CABs)
      6. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Indication, 2026 - 2033
      1. Gastroesophageal Reflux Disease (GERD)
      2. Peptic Ulcer Disease (PUD)
      3. H. pylori Infection
      4. Stress Ulcer Prophylaxis
      5. Zollinger-Ellison Syndrome
      6. Nonsteroidal Anti-Inflammatory Drug (NSAID)-Induced Gastropathy Prophylaxis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Intravenous
    7. Market Attractiveness Analysis
  9. East Asia Proton Pump Inhibitors (PPI) Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Drug Class
      3. By Therapeutic Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 - 2033
      1. Omeprazole
      2. Esomeprazole
      3. Pantoprazole
      4. Lansoprazole
      5. Potassium-Competitive Acid Blockers (P-CABs)
      6. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Indication, 2026 - 2033
      1. Gastroesophageal Reflux Disease (GERD)
      2. Peptic Ulcer Disease (PUD)
      3. H. pylori Infection
      4. Stress Ulcer Prophylaxis
      5. Zollinger-Ellison Syndrome
      6. Nonsteroidal Anti-Inflammatory Drug (NSAID)-Induced Gastropathy Prophylaxis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Intravenous
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Proton Pump Inhibitors (PPI) Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Drug Class
      3. By Therapeutic Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 - 2033
      1. Omeprazole
      2. Esomeprazole
      3. Pantoprazole
      4. Lansoprazole
      5. Potassium-Competitive Acid Blockers (P-CABs)
      6. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Indication, 2026 - 2033
      1. Gastroesophageal Reflux Disease (GERD)
      2. Peptic Ulcer Disease (PUD)
      3. H. pylori Infection
      4. Stress Ulcer Prophylaxis
      5. Zollinger-Ellison Syndrome
      6. Nonsteroidal Anti-Inflammatory Drug (NSAID)-Induced Gastropathy Prophylaxis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Intravenous
    7. Market Attractiveness Analysis
  11. Latin America Proton Pump Inhibitors (PPI) Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Drug Class
      3. By Therapeutic Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 - 2033
      1. Omeprazole
      2. Esomeprazole
      3. Pantoprazole
      4. Lansoprazole
      5. Potassium-Competitive Acid Blockers (P-CABs)
      6. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Indication, 2026 - 2033
      1. Gastroesophageal Reflux Disease (GERD)
      2. Peptic Ulcer Disease (PUD)
      3. H. pylori Infection
      4. Stress Ulcer Prophylaxis
      5. Zollinger-Ellison Syndrome
      6. Nonsteroidal Anti-Inflammatory Drug (NSAID)-Induced Gastropathy Prophylaxis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Intravenous
    7. Market Attractiveness Analysis
  12. Middle East & Africa Proton Pump Inhibitors (PPI) Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Drug Class
      3. By Therapeutic Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2026 - 2033
      1. Omeprazole
      2. Esomeprazole
      3. Pantoprazole
      4. Lansoprazole
      5. Potassium-Competitive Acid Blockers (P-CABs)
      6. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Indication, 2026 - 2033
      1. Gastroesophageal Reflux Disease (GERD)
      2. Peptic Ulcer Disease (PUD)
      3. H. pylori Infection
      4. Stress Ulcer Prophylaxis
      5. Zollinger-Ellison Syndrome
      6. Nonsteroidal Anti-Inflammatory Drug (NSAID)-Induced Gastropathy Prophylaxis
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Intravenous
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Pfizer Inc.
        1. Overview
        2. Segments and Deployments
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. AstraZeneca PLC
      3. Takeda Pharmaceutical Company Limited
      4. Bayer AG
      5. Sanofi S.A.
      6. Sun Pharmaceutical Industries Ltd.
      7. Dr. Reddy’s Laboratories Ltd.
      8. Cipla Limited
      9. Aurobindo Pharma Limited
      10. Teva Pharmaceutical Industries Ltd.
      11. Viatris Inc.
      12. Abbott Laboratories
      13. GlaxoSmithKline plc
      14. Lupin Limited
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate